Article Synopsis

  • Research indicates that the Microviridae bacteriophages, especially Gokushovirus WZ-2015a, are linked to food addiction and obesity in humans.
  • The study shows that Gokushovirus affects serotonin and dopamine metabolism, which are critical for regulating eating behaviors.
  • In experiments with mice, transferring gut microbiota and viruses from humans with high Gokushovirus levels led to increased food addiction, but supplementing with anthranilic acid reduced this effect by influencing neurotransmitter pathways.

Video Abstracts
Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Food addiction contributes to the obesity pandemic, but the connection between how the gut microbiome is linked to food addiction remains largely unclear. Here we show that Microviridae bacteriophages, particularly Gokushovirus WZ-2015a, are associated with food addiction and obesity across multiple human cohorts. Further analyses reveal that food addiction and Gokushovirus are linked to serotonin and dopamine metabolism. Mice receiving faecal microbiota and viral transplantation from human donors with the highest Gokushovirus load exhibit increased food addiction along with changes in tryptophan, serotonin and dopamine metabolism in different regions of the brain, together with alterations in dopamine receptors. Mechanistically, targeted tryptophan analysis shows lower anthranilic acid (AA) concentrations associated with Gokushovirus. AA supplementation in mice decreases food addiction and alters pathways related to the cycle of neurotransmitter synthesis release. In Drosophila, AA regulates feeding behaviour and addiction-like ethanol preference. In summary, this study proposes that bacteriophages in the gut microbiome contribute to regulating food addiction by modulating tryptophan and tyrosine metabolism.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s42255-024-01157-xDOI Listing

Publication Analysis

Top Keywords

food addiction
32
microviridae bacteriophages
8
food
8
addiction
8
tryptophan tyrosine
8
gut microbiome
8
serotonin dopamine
8
dopamine metabolism
8
bacteriophages influence
4
influence behavioural
4

Similar Publications

The increased workload and constant fear for life can cause significant stress and depression among healthcare workers (HCWs). The aim of this study was to measure psychological stress, depression, and their causes in HCWs who practiced in the Gaza strip since the 2023 Israel-Gaza war. We conducted a cross-sectional survey between April 2024 and January 2025 for Palestinian and international HCWs who practiced in the Gaza strip after October 7, 2023.

View Article and Find Full Text PDF

Investigating the mechanism of gastrodin-regulated miR-128-3p in methamphetamine dependence via integrated pharmacology.

Medicine (Baltimore)

September 2025

Department of Pharmacology of Chinese Medicine, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.

Gastrodin (GAS), the principal bioactive component derived from Gastrodia elata Bl., has demonstrated efficacy in attenuating methamphetamine (MA) induced conditioned place preference (CPP) in animal models. However, the molecular mechanisms underlying its anti-addictive effects, particularly the role of miRNAs, remain insufficiently understood.

View Article and Find Full Text PDF

The current electronic cigarette (e-cigarette) format was made known to the public in recent decades. Since then, it has gained widespread popularity, particularly among adolescents. A significant portion of young people in the United States and around the world are reported to use e-cigarettes.

View Article and Find Full Text PDF

Background: Substance use disorders (SUD) are associated with metabolic dysregulation and nutritional deficiencies. Studies show that incorporating nutrition interventions into treatment may improve physical and psychological health. This study sought to explore dietary and consumer behavior in individuals currently using substances.

View Article and Find Full Text PDF

Ever since its discovery, glucagon-like-peptide 1 (GLP-1) and drugs with similar function (collectively GLP-1s) have been used for type 2 diabetes mellitus and have been effective for obesity. Their profound effect on weight loss has resulted in widespread use of these medicines for treating obesity. Extensive studies have shown that GLP-1s decrease body weight, lean mass, and other metabolic phenotypes.

View Article and Find Full Text PDF